{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"5"}],"units":"Participants"}],"description":"Patients who developed chronic graft-versus-host disease.","groups":[{"description":"Patients who received complement fragment 3a (C3a) priming of the UCB unit with the smaller cell dose following preparation regimen and radiation.","id":"OG000","title":"Complement Fragment 3A - Small Cell Dose"},{"description":"Patients who received complement fragment 3a (C3a) priming of the UCB unit with the larger cell dose.","id":"OG001","title":"Complement Fragment A - Larger Cell Dose"}],"paramType":"NUMBER","populationDescription":"Two patients were unevaluable - one, because 1 bag of cord blood broke leaving only 1 cord available, and one subject never received the C3a.","reportingStatus":"POSTED","timeFrame":"Day 360","title":"Chronic Graft-Versus-Host Disease","type":"SECONDARY","unitOfMeasure":"participants"}